- Home
- BVS vs GLRE Comparison
BVS vs GLRE Comparison
Compare BVS & GLRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BVS
- GLRE
- Stock Information
- Founded
- BVS 2011
- GLRE 2004
- Country
- BVS United States
- GLRE Cayman Islands
- Employees
- BVS N/A
- GLRE N/A
- Industry
- BVS Biotechnology: Electromedical & Electrotherapeutic Apparatus
- GLRE Property-Casualty Insurers
- Sector
- BVS Health Care
- GLRE Finance
- Exchange
- BVS Nasdaq
- GLRE Nasdaq
- Market Cap
- BVS 432.7M
- GLRE 453.5M
- IPO Year
- BVS 2021
- GLRE 2007
- Fundamental
- Price
- BVS $7.63
- GLRE $13.18
- Analyst Decision
- BVS Strong Buy
- GLRE
- Analyst Count
- BVS 5
- GLRE 0
- Target Price
- BVS $14.40
- GLRE N/A
- AVG Volume (30 Days)
- BVS 542.4K
- GLRE 110.4K
- Earning Date
- BVS 08-06-2025
- GLRE 08-04-2025
- Dividend Yield
- BVS N/A
- GLRE N/A
- EPS Growth
- BVS N/A
- GLRE N/A
- EPS
- BVS 0.03
- GLRE 1.10
- Revenue
- BVS $564,142,000.00
- GLRE $695,657,000.00
- Revenue This Year
- BVS N/A
- GLRE N/A
- Revenue Next Year
- BVS $6.26
- GLRE N/A
- P/E Ratio
- BVS $277.70
- GLRE $11.88
- Revenue Growth
- BVS 5.08
- GLRE 0.97
- 52 Week Low
- BVS $5.81
- GLRE $12.14
- 52 Week High
- BVS $14.38
- GLRE $15.82
- Technical
- Relative Strength Index (RSI)
- BVS 62.12
- GLRE 50.69
- Support Level
- BVS $7.03
- GLRE $12.89
- Resistance Level
- BVS $7.48
- GLRE $13.39
- Average True Range (ATR)
- BVS 0.43
- GLRE 0.26
- MACD
- BVS 0.05
- GLRE 0.06
- Stochastic Oscillator
- BVS 94.49
- GLRE 73.75
About BVS Bioventus Inc.
Bioventus Inc is a medical technology company. The company is engaged in developing and commercializing clinically differentiated treatments that engage and enhance the body's natural healing process. It offers a diverse portfolio of products to serve physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine and neurosurgery. Its portfolio of products is grouped into three verticals based on clinical use: Pain Treatments, Surgical Solutions, and Restorative Therapies. Geographical presence is in the United States which derives key revenue, and International markets.
About GLRE Greenlight Capital Re Ltd.
Greenlight Capital Re Ltd offers property and casualty reinsurance. Its customers are property and casualty insurers, and Greenlight takes on some of their risk in exchange for insurance premiums. It operates through one operating segment: property and casualty reinsurance. It generates revenue through premiums from reinsurance on property and casualty business assumed and income from investments.